๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol

โœ Scribed by I.D. Peyron; I.L. Britto; L.B. Benissan; B.Z. Tardieu


Book ID
116871233
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
242 KB
Volume
99
Category
Article
ISSN
0954-6111

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Beclomethasone relative availability of
โœ Inmaculada Soria; Lester I. Harrison; Jane H. Machacek; Ann C. Cline; Patti A. S ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 145 KB

3M has formulated a new chlorofluorocarbon-free (CFC-free) beclomethasone dipropionate (BDP) metered-dose inhaler (MDI) with the use of the propellant HFA-134a (HFA). Lung deposition studies demonstrated that the HFA BDP MDI delivers to the lungs approximately 56% of the BDP dose (ex-adaptor), a sub